Company Filing History:
Years Active: 2019-2021
Title: Aki Nakatani: Innovator in Antibody Development
Introduction
Aki Nakatani is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 3 patents to his name, Nakatani's work is paving the way for advancements in medical treatments.
Latest Patents
One of Nakatani's latest patents involves an anti-EphA4 antibody. This innovative antibody is designed to bind to EphA4 and enhance its cleavage. The patent also includes a pharmaceutical composition that comprises the antibody as the active ingredient. A mouse anti-EphA4 antibody was developed, which has a binding affinity towards EphA4 and can enhance its cleavage. The sequence of the complementarity-determining region (CDR) of this mouse antibody was identified, leading to the production of a humanized version of the antibody.
Career Highlights
Aki Nakatani is currently associated with Eisai R&D Management Co., Ltd. His work at this company has been instrumental in advancing research in antibody therapies. Nakatani's innovative approach and dedication to his field have earned him recognition among his peers.
Collaborations
Nakatani has collaborated with notable coworkers, including Toshio Imai and Eiji Inoue. These collaborations have further enriched his research and contributed to the success of his projects.
Conclusion
Aki Nakatani's contributions to the field of biotechnology, particularly in the development of anti-EphA4 antibodies, highlight his innovative spirit and commitment to advancing medical science. His work continues to inspire future research and development in antibody therapies.